David Hui Shao, Ph.D., MBA, CFA, CPA

David Hui Shao, Ph.D., MBA, CFA, CPA, is a biopharma and finance executive with 20+ years of leadership across healthcare, capital markets, and corporate governance. He has served as CEO and CFO of U.S.-listed companies, leading IPOs in the U.S. and Hong Kong while driving multinational expansion. Earlier in his career, he was a senior biotech analyst and investor on Wall Street, helping build a global biotech investor base that included Fidelity, OrbiMed, the Gates Foundation, Hillhouse, and C-Bridge.
 

As co-founder and president of Tribridge Bio, Dr. Shao blends scientific expertise from Roche with proven financial acumen to connect innovators with global investors. He helps partners scale operations, secure funding, and accelerate innovation, positioning Tribridge Bio as a trusted partner for life sciences companies worldwide